Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Svedbom

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
JAMA Dermatology|November 20, 2024
Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in PsoriasisAxel Svedbom, Lotus Mallbris, Álvaro González-Cantero, et al.
The Lancet. Rheumatology|June 30, 2026
Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort studyAxel Svedbom, Lotus Mallbris, Alen Zabotti, et al.
Advances in Therapy|November 9, 2021
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational StudyJohan Dalén, Anushri Chitkara, Axel Svedbom, et al.
Acta Dermato-Venereologica|March 14, 2015
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register studyAxel Svedbom, Johan Dalén, Carla Mamolo, et al.
Rheumatology International|January 19, 2016
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistenceJohan Dalén, Axel Svedbom, Christopher M Black, et al.
Clinical Epidemiology|April 3, 2024
Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort StudyDavid Bergman, Bjorn Roelstraete, Jiangwei Sun, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 15, 2021
Thirty years of hip fracture incidence in Austria: is the worst over?Hans Peter Dimai, Berthold Reichardt, Emanuel Zitt, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome PredictionEmil Lou, Valentino Clemente, Marcel Grube, et al.
Current Medical Research and Opinion|September 12, 2015
Is dibotermin alfa a cost-effective substitute for autologous iliac crest bone graft in single level lumbar interbody spine fusion?Axel Svedbom, Daniel Paech, Catherine Leonard, et al.
JAMA Network Open|February 27, 2024
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian CancerEmil Lou, Valentino Clemente, Marcel Grube, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
JAMA Dermatology|November 20, 2024
Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in PsoriasisAxel Svedbom, Lotus Mallbris, Álvaro González-Cantero, et al.
The Lancet. Rheumatology|June 30, 2026
Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort studyAxel Svedbom, Lotus Mallbris, Alen Zabotti, et al.
Advances in Therapy|November 9, 2021
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational StudyJohan Dalén, Anushri Chitkara, Axel Svedbom, et al.
Acta Dermato-Venereologica|March 14, 2015
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register studyAxel Svedbom, Johan Dalén, Carla Mamolo, et al.
Rheumatology International|January 19, 2016
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistenceJohan Dalén, Axel Svedbom, Christopher M Black, et al.
Clinical Epidemiology|April 3, 2024
Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort StudyDavid Bergman, Bjorn Roelstraete, Jiangwei Sun, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 15, 2021
Thirty years of hip fracture incidence in Austria: is the worst over?Hans Peter Dimai, Berthold Reichardt, Emanuel Zitt, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome PredictionEmil Lou, Valentino Clemente, Marcel Grube, et al.
Current Medical Research and Opinion|September 12, 2015
Is dibotermin alfa a cost-effective substitute for autologous iliac crest bone graft in single level lumbar interbody spine fusion?Axel Svedbom, Daniel Paech, Catherine Leonard, et al.
JAMA Network Open|February 27, 2024
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian CancerEmil Lou, Valentino Clemente, Marcel Grube, et al.
Pageof 5